ProfileGDS5822 / ILMN_1254431
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 20% 50% 40% 42% 21% 52% 39% 63% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11320
GSM1276600PDAC Late Ablation Control 22450
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.140
GSM1276603PDAC Late Ablation 219.242
GSM1276604PDAC Late Ablation 312.321
GSM1303940PDAC Late Ablation_anti-CTLA4 123.252
GSM1303941PDAC Late Ablation_anti-CTLA4 218.639
GSM1303942PDAC Late Ablation_anti-CTLA4 343.763